期刊
ATHEROSCLEROSIS
卷 221, 期 1, 页码 226-231出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2011.12.025
关键词
Endothelial microparticles; Ischemia; Acute myocardial infarction; Hypoxia
资金
- Swedish Heart and Lung Foundation
- Swedish Research Council [10857]
- Karolinska Institutet/Stockholm County Council
- Gustav V and Queen Victoria Foundation
- Novo Nordisk Foundation
Objectives: Microparticles (MP) are small membrane vesicles, released from activated, damaged and apoptotic endothelial cells (EMP) or platelets (PMP) that may actively modulate inflammation, coagulation and vascular function. We tested the hypothesis that the number of circulating EMP or PMP in acute myocardial infarction correlates with the myocardium at risk (MaR) and infarct size (IS). Methods: EMP were quantified in plasma samples of 36 patients (age: 63 +/- 10 years) with first time ST-elevation myocardial infarction (STEMI) using flow cytometry. EMP were defined as CD31(+)/CD42(-) MP and CD144(+) MP and PMP as CD31(+)/CD42(+) MP. MaR and IS was determined by cardiovascular magnetic resonance imaging one week after the index event. Results: Plasma levels of CD31(+)/CD42(-) EMP were 251.0 +/- 178.8/mu l and CD144(+) 106.3 +/- 33.7/mu l. PMP levels were 579.2 +/- 631.8/mu l. MaR was 31.0 +/- 11.2% of the left ventricle and IS was 11.4 +/- 7.1% of the left ventricle. Patients with STEMI in the left anterior descending artery had higher levels of CD31(+)/CD42(-) EMP and PMP than those with other infarct-related arteries (p<0.05). The numbers of CD31(+)/CD42(-) EMP and PMP correlated to MaR, but not to IS. Conclusions: Circulating EMP and PMP correlate to the size of MaR in patients with STEMI suggesting that they reflect the severity of the endothelial injury and platelet activation during myocardial ischemia. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据